Strong Buy
Average AnalystStrong Buy
Top AnalystBearish
Stock Target AdvisorStrong Buy
Average UserUSD 27.24
+0.24 (+0.89)%
USD 1.73B
1.00M
USD 29.74(+9.17%)
Symbol | Name | Exchange | NRIX's Weight | Expense Ratio | Price(Change) | Market Cap |
---|---|---|---|---|---|---|
|
ARK Genomic Revolution UC.. | LSE | 4.78 % | 0.00 % | +6.78 (+1.88%) | USD3.68M |
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
The stock is trading high compared to its peers median on a price to book value basis.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The company had negative total cash flow in the most recent four quarters.
The company had negative total free cash flow in the most recent four quarters.
This stock has shown below median earnings growth in the previous 5 years compared to its sector